Back to 
Belvedere Trading LLC
Belvedere Trading LLC
CORT
Showing 0 of 2 quarters
Position history for Belvedere Trading LLC's holdings in Corcept Therapeutics Incorporated.
No. Belvedere Trading exited its CORT (Corcept Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 12,624 shares worth $293,000. Belvedere Trading first reported CORT in Q1 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.